What type of drug is Copiktra?
Medically reviewed by Drugs.com. Last updated on Oct 5, 2020.
Copiktra is a first-in-class, oral inhibitor of PI3K-delta and PI3K-gamma, two enzymes that boost survival of malignant B-cells (an overgrowth of a type of white blood cell in your immune system).
Copiktra (duvelisib), from Verastem Oncology, is used to treat two types of blood cancers in adults:
- relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
- relapsed or refractory follicular lymphoma (FL), when the patient has received at least two prior therapies.
CLL/SLL and FL are common types of indolent (slow-growing) non-Hodgkin lymphomas (iNHL).
Related Medical Questions
- How will I feel after a Rituxan infusion?
- How long does it take for Rituxan to work?
- How does the drug Rituxan work?
- How do you prepare for a Rituxan infusion?
- Is Venclexta (venetoclax) chemotherapy?
- How long do you take Venclexta for?
- What is the difference between Truxima and Rituxan?
- How effective is Venclexta?
- How is Bendeka different to Treanda?
- What is the difference between Rituxan and Rituxan Hycela?
- What are the names of the BTK inhibitors?
- How does Venclexta work?